Advertising
Supported by
Agency leaders said there was evidence to justify approval only for the elderly and others with medical conditions. Many others would possibly not be to get the blows.
By Christina Jewett and Apoorva Mandavilli
The Food and Drug Administration will allow Covid vaccines to be used through adults 65 and older and those with safe medical situations in the fall, but they would possibly require more studies before approving the shots for healthy Americans under 65, firm officials said Tuesday.
At this stage, the additional doses offer “uncertain” benefits for many young and average ages who have already been vaccinated or have had a nucleus, Dr. Vinay Prasad, the F. D. A. Chief of vaccines, and Dr. Martin Makary, commissioner of signatures, in the New England Journal of Medicine.
“The F. D. A. will approve vaccines for high-risk Americans while also requiring robust knowledge of low-risk Americans,” the officials wrote.
Until now, the annual Covid plans have been advised by everyone over 6 months old. Scientific advisors of the F. D. A. are in a position to meet on Thursday on the composition of the Covid vaccine to be made in the autumn.
Throughout the pandemic, Dr. Prasad and Dr. Makary have been vocal critics of vaccine mandates and public fitness measures aimed at reversing the coronavirus.
Robert F. Kennedy Jr. , the Secretary of Health, is a longtime vaccine skeptic who has spent years campaigning in opposition to couples, wrongly claiming that the vaccines had killed more people than the virus.
We are having to recover the content of the article.
Turn on JavaScript in your browser settings.
Thank you for your patience as we review access. If you’re in reader mode, drop off and attach to your Times account, or subscribe to all the time.
Thank you for your patience as we determine access.
Already subscribed? Connect.
Do you want all the time? Subscribe.
Advertising